mrcc: how an approved i-o regimen impacts treatment
Published 5 years ago • 73 plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
9:05
mrcc: when is tki/i-o combination therapy appropriate?
-
7:55
mrcc: identifying and managing aes in tkis and io therapy
-
4:53
emerging tki/i-o options in mrcc
-
6:40
evaluating i-o monotherapy’s value in treating mrcc
-
1:01
dr. ho on frontline treatment regimens in mrcc
-
11:18
ecmo cytosorb integration
-
6:17
how to get your doctor to order an mri or ct/cat scan
-
7:38
unresectable stage iii lung cancer management
-
7:01
patient factor consideration for treatment of mrcc
-
7:55
choosing upfront therapy for mrcc
-
4:05
therapy selection for patients with newly diagnosed mrcc
-
1:20
mr explained #2 - changing ed and es phases 2020
-
1:23
mycme: specialty board cme requirements
-
1:22
dr. somer on immunotherapy combinations in mrcc
-
5:14
common eye conditions and how you can manage them?
-
4:27
vegf-tki therapy in first-line mrcc
-
1:06
dr. lee on treatment options in mrcc
-
3:15
a novel approach: tki/i-o combinations in rcc
-
15:05
ecmo therapy - detail explanation
-
9:13
introduction: surgical approaches in mrcc
-
6:36
choosing second-line therapy in treatment of mrcc